StockDriftsStockDriftsTop 36 Commodore Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 9.79% | 17.00M | $169.2M | +0.00%(+0) | $3.36(+455.33%) | 2026-03-31 | |
| ALKS | ALKERMES PLC | 8.59% | 4.20M | $148.5M | +18.31%(+650.00K) | $28.21(+93.46%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 7.43% | 3.27M | $128.4M | -30.21%(-1.42M) | $18.84(+164.43%) | 2026-03-31 | |
| COGT | COGENT BIOSCIENCES INC | 6.43% | 2.89M | $111.2M | +31.46%(+691.16K) | $16.40(+135.97%) | 2026-03-31 | |
| SYRE | SPYRE THERAPEUTICS INC | 5.58% | 1.91M | $96.5M | -19.93%(-475.87K) | $18.44(+369.89%) | 2026-03-31 | |
| TYRA | TYRA BIOSCIENCES INC | 5.48% | 2.48M | $94.8M | -26.67%(-900.00K) | $10.39(+194.84%) | 2026-03-31 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 4.95% | 2.70M | $85.5M | +5.13%(+131.62K) | $27.34(+40.34%) | 2026-03-31 | |
| NUVL | NUVALENT INC | 4.94% | 833.6K | $85.4M | +51.56%(+283.60K) | $76.97(+60.74%) | 2026-03-31 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 4.54% | 5.65M | $78.5M | +0.00%(+0) | $10.79(+69.32%) | 2026-03-31 | |
| KYMR | KYMERA THERAPEUTICS INC | 3.61% | 750.0K | $62.5M | +0.00%(+0) | $36.63(+209.88%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +32.90% | +134.71% |
| Top 20 Holdings Unweighted | +38.30% | +164.53% |
Sign up free to track Commodore Capital LP, compare funds side by side, and get alerts the moment positions change.